Exelixis | Salg

Sales Lave om Dato
Acadia Pharmaceuticals USD 231.04M 19.34M 2023-12
Agios Pharmaceuticals USD 8.19M 1.09M 2024-03
Amgen USD 7.45B 746M 2024-03
AstraZeneca USD 12.02B 532M 2023-12
Bayer EUR 11.86B 1.52B 2023-12
BioMarin Pharmaceutical USD 649M 2.79M 2024-03
Bristol-Myers Squibb USD 11.9B 423M 2024-03
Cytokinetics USD 1.67M 1.29M 2023-12
Eisai JPY 177.7B 1.09B 2023-12
Eli Lilly USD 8.77B 583.4M 2024-03
Exelixis USD 425M 54.65M 2024-03
Genmab DKK 4.68B 66M 2023-12
Glaxosmithkline GBP 8.05B 95M 2023-12
Incyte USD 880.89M 132.45M 2024-03
Ionis Pharmaceuticals USD 325M 180.79M 2023-12
MacroGenics USD 10.72M 323K 2023-12
Merck USD 15.8B 1.17B 2024-03
Moderna USD 167B 164.19B 2024-03
Neurocrine Biosciences USD 515.3M 100K 2024-03
Novartis USD 11.83B 54M 2024-03
Pfizer USD 14.9B 651M 2024-03
Sanofi EUR 11.75B 1.26B 2023-12
Takeda JPY 1.11T 68.1B 2023-12
Ultragenyx Pharmaceutical USD 108.8M 18.59M 2024-03
Xencor USD 44.69M 14.48M 2023-12



Exelixis Salg - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2024.